In this article, we are going to take a look at where Evoke Pharma, Inc. (NASDAQ:EVOK) stands against the other diabetes stocks. About 422 million people worldwide have diabetes, according to the ...
StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a research note released on Sunday. The brokerage issued a sell rating on the specialty pharmaceutical company’s ...